Cargando…

Severe dyspnea in a patient with neurofibromatosis type 1

Neurofibromatosis type 1 (NF1) is a genetic disease in which pulmonary complications are rare, but severe, especially pulmonary hypertension (PH). The mechanisms underlying the onset of PH in patients with NF1 are unclear and might be multifactorial. In particular, the frequent presence of pulmonary...

Descripción completa

Detalles Bibliográficos
Autores principales: Poble, P.B., Dalphin, J.C., Degano, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491756/
https://www.ncbi.nlm.nih.gov/pubmed/28702341
http://dx.doi.org/10.1016/j.rmcr.2017.06.008
_version_ 1783247195575681024
author Poble, P.B.
Dalphin, J.C.
Degano, B.
author_facet Poble, P.B.
Dalphin, J.C.
Degano, B.
author_sort Poble, P.B.
collection PubMed
description Neurofibromatosis type 1 (NF1) is a genetic disease in which pulmonary complications are rare, but severe, especially pulmonary hypertension (PH). The mechanisms underlying the onset of PH in patients with NF1 are unclear and might be multifactorial. In particular, the frequent presence of pulmonary parenchymal lesions makes etiological diagnosis of PH difficult. We describe here the case of a patient with NF1 admitted to our clinic with dyspnea and right heart failure revealing severe pre-capillary PH. Parenchymal lesions were mild and PH was attributed to pulmonary vascular involvement. Clinical and hemodynamic conditions of the patient improved under pulmonary arterial hypertension-specific combination therapy. This case suggests that treatment of PH due to pulmonary vascular involvement in NF1 may be aligned with recommendations for PAH treatment.
format Online
Article
Text
id pubmed-5491756
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-54917562017-07-12 Severe dyspnea in a patient with neurofibromatosis type 1 Poble, P.B. Dalphin, J.C. Degano, B. Respir Med Case Rep Case Report Neurofibromatosis type 1 (NF1) is a genetic disease in which pulmonary complications are rare, but severe, especially pulmonary hypertension (PH). The mechanisms underlying the onset of PH in patients with NF1 are unclear and might be multifactorial. In particular, the frequent presence of pulmonary parenchymal lesions makes etiological diagnosis of PH difficult. We describe here the case of a patient with NF1 admitted to our clinic with dyspnea and right heart failure revealing severe pre-capillary PH. Parenchymal lesions were mild and PH was attributed to pulmonary vascular involvement. Clinical and hemodynamic conditions of the patient improved under pulmonary arterial hypertension-specific combination therapy. This case suggests that treatment of PH due to pulmonary vascular involvement in NF1 may be aligned with recommendations for PAH treatment. Elsevier 2017-06-17 /pmc/articles/PMC5491756/ /pubmed/28702341 http://dx.doi.org/10.1016/j.rmcr.2017.06.008 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Poble, P.B.
Dalphin, J.C.
Degano, B.
Severe dyspnea in a patient with neurofibromatosis type 1
title Severe dyspnea in a patient with neurofibromatosis type 1
title_full Severe dyspnea in a patient with neurofibromatosis type 1
title_fullStr Severe dyspnea in a patient with neurofibromatosis type 1
title_full_unstemmed Severe dyspnea in a patient with neurofibromatosis type 1
title_short Severe dyspnea in a patient with neurofibromatosis type 1
title_sort severe dyspnea in a patient with neurofibromatosis type 1
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491756/
https://www.ncbi.nlm.nih.gov/pubmed/28702341
http://dx.doi.org/10.1016/j.rmcr.2017.06.008
work_keys_str_mv AT poblepb severedyspneainapatientwithneurofibromatosistype1
AT dalphinjc severedyspneainapatientwithneurofibromatosistype1
AT deganob severedyspneainapatientwithneurofibromatosistype1